sur Defence Therapeutics Inc. (isin : CA24463V1013)
Defence Therapeutics to Attend 2024 SNMMI Annual Meeting in Toronto
Defence Therapeutics Inc. announced its participation in the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. The event will be held on June 11, 2024, at the Metro Toronto Convention Centre.
SNMMI is a leading organization promoting the science and practical application of nuclear medicine and molecular imaging. Their annual meeting offers an in-depth view of the latest research in the field, aiming to improve human health. The gathering is recognized as a premier event for networking and professional development in radiotherapy and molecular imaging.
Defence is collaborating with Orano Support SAS to develop AccuTRIC™, a novel Radio-Immuno-Conjugate. This project focuses on utilizing Auger electron emitters to treat hard-to-reach cancers, enhancing the efficacy while minimizing radiotoxicity on healthy tissues.
R. H.Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés. Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Defence Therapeutics Inc.